264 related articles for article (PubMed ID: 31005224)
1. Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases.
Werensteijn-Honingh AM; Kroon PS; Winkel D; Aalbers EM; van Asselen B; Bol GH; Brown KJ; Eppinga WSC; van Es CA; Glitzner M; de Groot-van Breugel EN; Hackett SL; Intven M; Kok JGM; Kontaxis C; Kotte AN; Lagendijk JJW; Philippens MEP; Tijssen RHN; Wolthaus JWH; Woodings SJ; Raaymakers BW; Jürgenliemk-Schulz IM
Radiother Oncol; 2019 May; 134():50-54. PubMed ID: 31005224
[TBL] [Abstract][Full Text] [Related]
2. Simulated dosimetric impact of online replanning for stereotactic body radiation therapy of lymph node oligometastases on the 1.5T MR-linac.
Winkel D; Kroon PS; Werensteijn-Honingh AM; Bol GH; Raaymakers BW; Jürgenliemk-Schulz IM
Acta Oncol; 2018 Dec; 57(12):1705-1712. PubMed ID: 30280631
[TBL] [Abstract][Full Text] [Related]
3. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.
Winkel D; Bol GH; Werensteijn-Honingh AM; Intven MPW; Eppinga WSC; Hes J; Snoeren LMW; Sikkes GG; Gadellaa-van Hooijdonk CGM; Raaymakers BW; Jürgenliemk-Schulz IM; Kroon PS
Radiother Oncol; 2020 May; 146():118-125. PubMed ID: 32146257
[TBL] [Abstract][Full Text] [Related]
4. First clinical experiences with a high field 1.5 T MR linac.
Bertelsen AS; Schytte T; Møller PK; Mahmood F; Riis HL; Gottlieb KL; Agergaard SN; Dysager L; Hansen O; Gornitzka J; Veldhuizen E; ODwyer DB; Christiansen RL; Nielsen M; Jensen HR; Brink C; Bernchou U
Acta Oncol; 2019 Oct; 58(10):1352-1357. PubMed ID: 31241387
[No Abstract] [Full Text] [Related]
5. Dosimetric feasibility of hypofractionation for SBRT treatment of lymph node oligometastases on the 1.5T MR-linac.
Winkel D; Werensteijn-Honingh AM; Eppinga WSC; Intven MPW; Hes J; Snoeren LMW; Visser SA; Bol GH; Raaymakers BW; Jürgenliemk-Schulz IM; Kroon PS
Radiother Oncol; 2021 Jan; 154():243-248. PubMed ID: 32949691
[TBL] [Abstract][Full Text] [Related]
6. Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases.
Werensteijn-Honingh AM; Jürgenliemk-Schulz IM; Gadellaa-Van Hooijdonk CG; Sikkes GG; Vissers NGPM; Winkel D; Eppinga WSC; Intven M; Raaymakers BW; Kroon PS
Radiother Oncol; 2021 Jan; 154():110-117. PubMed ID: 32950531
[TBL] [Abstract][Full Text] [Related]
7. Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases.
Cuccia F; Rigo M; Gurrera D; Nicosia L; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Attinà G; Pastorello E; De Simone A; Naccarato S; Sicignano G; Ruggieri R; Alongi F
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3269-3277. PubMed ID: 34268583
[TBL] [Abstract][Full Text] [Related]
8. Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
McDonald BA; Vedam S; Yang J; Wang J; Castillo P; Lee B; Sobremonte A; Ahmed S; Ding Y; Mohamed ASR; Balter P; Hughes N; Thorwarth D; Nachbar M; Philippens MEP; Terhaard CHJ; Zips D; Böke S; Awan MJ; Christodouleas J; Fuller CD;
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1606-1618. PubMed ID: 33340604
[TBL] [Abstract][Full Text] [Related]
9. A daily end-to-end quality assurance workflow for MR-guided online adaptive radiation therapy on MR-Linac.
Chen X; Ahunbay E; Paulson ES; Chen G; Li XA
J Appl Clin Med Phys; 2020 Jan; 21(1):205-212. PubMed ID: 31799753
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes.
Mazzola R; Cuccia F; Figlia V; Rigo M; Nicosia L; Giaj-Levra N; Ricchetti F; Vitale C; Mantoan B; Di Paola G; De Simone A; Gurrera D; Sicignano G; Naccarato S; Ruggieri R; Alongi F
Radiol Med; 2021 Jul; 126(7):989-997. PubMed ID: 33835309
[TBL] [Abstract][Full Text] [Related]
11. Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer.
Jereczek-Fossa BA; Fariselli L; Beltramo G; Catalano G; Serafini F; Garibaldi C; Cambria R; Brait L; Possanzini M; Bianchi LC; Vavassori A; Zerini D; Orsi F; de Cobelli O; Orecchia R
Radiother Oncol; 2009 Oct; 93(1):14-7. PubMed ID: 19409636
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of an electronic portal imaging based in vivo dose verification system for prostate stereotactic body radiotherapy.
Yedekci Y; Biltekin F; Ozyigit G
Phys Med; 2019 Aug; 64():204-209. PubMed ID: 31515021
[TBL] [Abstract][Full Text] [Related]
13. 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.
Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
Radiat Oncol; 2020 Mar; 15(1):69. PubMed ID: 32248826
[TBL] [Abstract][Full Text] [Related]
14. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
Intven MPW; de Mol van Otterloo SR; Mook S; Doornaert PAH; de Groot-van Breugel EN; Sikkes GG; Willemsen-Bosman ME; van Zijp HM; Tijssen RHN
Radiother Oncol; 2021 Jan; 154():172-178. PubMed ID: 32976875
[TBL] [Abstract][Full Text] [Related]
15. Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.
Jereczek-Fossa BA; Beltramo G; Fariselli L; Fodor C; Santoro L; Vavassori A; Zerini D; Gherardi F; Ascione C; Bossi-Zanetti I; Mauro R; Bregantin A; Bianchi LC; De Cobelli O; Orecchia R
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):889-97. PubMed ID: 21277113
[TBL] [Abstract][Full Text] [Related]
16. Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation.
Zhou S; Luo L; Li J; Lin M; Chen L; Shao J; Lu S; Ma Y; Zhang Y; Chen W; Liu M; Liu S; He L
Radiat Oncol; 2019 Jan; 14(1):22. PubMed ID: 30696488
[TBL] [Abstract][Full Text] [Related]
17. Individual lymph nodes: "See it and Zap it".
Winkel D; Werensteijn-Honingh AM; Kroon PS; Eppinga WSC; Bol GH; Intven MPW; de Boer HCJ; Snoeren LMW; Hes J; Raaymakers BW; Jürgenliemk-Schulz IM
Clin Transl Radiat Oncol; 2019 Sep; 18():46-53. PubMed ID: 31341975
[TBL] [Abstract][Full Text] [Related]
18. Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer.
Poon DMC; Yang B; Geng H; Wong OL; Chiu ST; Cheung KY; Yu SK; Chiu G; Yuan J
J Cancer Res Clin Oncol; 2023 Feb; 149(2):841-850. PubMed ID: 35199189
[TBL] [Abstract][Full Text] [Related]
19. CyberKnife Stereotactic Ablative Radiotherapy as an Option of Treatment for Patients With Prostate Cancer Having Oligometastatic Lymph Nodes: Single-Center Study Outcome Evaluation.
Napieralska A; Miszczyk L; Stąpór-Fudzińska M
Technol Cancer Res Treat; 2016 Oct; 15(5):661-73. PubMed ID: 26208835
[TBL] [Abstract][Full Text] [Related]
20. [Primary treatment of prostate cancer using 1.5 T MR-linear accelerator].
Wegener D; Zips D; Gani C; Boeke S; Nikolaou K; Othman AE; Almansour H; Paulsen F; Müller AC
Radiologe; 2021 Sep; 61(9):839-845. PubMed ID: 34297139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
